Works in Cancer Chemotherapy & Pharmacology, 2014, Vol 74, Issue 4
Results: 25
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The effect of formulation and food consumption on the bioavailability of dovitinib (TKI258) in patients with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- Report
Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 691, doi. 10.1007/s00280-014-2501-1
- By:
- Publication type:
- Article
A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 839, doi. 10.1007/s00280-014-2513-x
- By:
- Publication type:
- Article
Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 681, doi. 10.1007/s00280-014-2522-9
- By:
- Publication type:
- Article
Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 675, doi. 10.1007/s00280-014-2526-5
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 831, doi. 10.1007/s00280-014-2535-4
- By:
- Publication type:
- Article
Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 661, doi. 10.1007/s00280-014-2536-3
- By:
- Publication type:
- Article
Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 739, doi. 10.1007/s00280-014-2539-0
- By:
- Publication type:
- Article
Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 667, doi. 10.1007/s00280-014-2541-6
- By:
- Publication type:
- Article
Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 699, doi. 10.1007/s00280-014-2543-4
- By:
- Publication type:
- Article
First-line gefitinib therapy for elderly patients with non-small cell lung cancer harboring EGFR mutation: Central Japan Lung Study Group 0901.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 721, doi. 10.1007/s00280-014-2548-z
- By:
- Publication type:
- Article
Anticancer activity of VDR-coregulator inhibitor PS121912.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 787, doi. 10.1007/s00280-014-2549-y
- By:
- Publication type:
- Article
Acetyl- l-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network
- Published in:
- 2014
- By:
- Publication type:
- Report
Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 799, doi. 10.1007/s00280-014-2551-4
- By:
- Publication type:
- Article
Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 809, doi. 10.1007/s00280-014-2552-3
- By:
- Publication type:
- Article
Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 757, doi. 10.1007/s00280-014-2553-2
- By:
- Publication type:
- Article
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 729, doi. 10.1007/s00280-014-2554-1
- By:
- Publication type:
- Article
A pharmacodynamic model of Bcr-Abl signalling in chronic myeloid leukaemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 765, doi. 10.1007/s00280-014-2556-z
- By:
- Publication type:
- Article
The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 847, doi. 10.1007/s00280-014-2557-y
- By:
- Publication type:
- Article
Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 751, doi. 10.1007/s00280-014-2558-x
- By:
- Publication type:
- Article
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 819, doi. 10.1007/s00280-014-2560-3
- By:
- Publication type:
- Article
Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 777, doi. 10.1007/s00280-014-2562-1
- By:
- Publication type:
- Article
A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 861, doi. 10.1007/s00280-014-2565-y
- By:
- Publication type:
- Article
Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 711, doi. 10.1007/s00280-014-2434-8
- By:
- Publication type:
- Article